o7 JUL, 2020

Luminary Therapeutics and Case Western Reserve University Enter Collaboration

Luminary Therapeutics and Case Western Reserve University enter formal collaboration for clinical development of novel BAFF CAR to treat Mantle Cell Lymphoma and Sjogren’s Syndrome. Read full press release.

21 JAN, 2020

Phacilitate Leaders World & World Stem Cell Summit 2020

Luminary’s VP of Corporate Development will be attending Phacilitate Leaders World & World Stem Cell Summit 2020 in Miami, Jan 21-24, 2020

12 NOV, 2019

Luminary files patent for Universal Receptor for Immunotherapy

Jeff Liter CEO of Luminary notes this universal receptor has the ability to disrupt targeting multiple cancer antigens invivo

04 MAR, 2019

Luminary Tx teams with 20 year licensing pharma veteran to seek novel CAR’s and TCR’s IP

Luminary is in negotiations with three key cancer centers for exclusive licenses of next generation CAR’s and TCR’s.

30 FEB, 2019

Dr. Arek Dudek MD teams up with Luminary in order to accelerate new Immunotherapies

Dr Dudek, hails from the Medical University of Warsaw, Poland; internal medicine residency, Pinnacle Health Hospitals, Harrisburg, PA; fellowship in hematology and oncology, and the University of Minnesota.

26 FEB, 2019

Luminary is initiating partnerships with key antibody companies

Luminary is initiating partnerships with key antibody companies to discover new Chimeric Antigen Receptors (CAR’s). Expect new announcements in the Spring of 2020.

20 FEB, 2019

Luminary will be submitting three SBIR grants on Jan 6 2020

David Largaespada notes that these grants if awarded will accelerate key research at Luminary for our prostate and pancreatic cancer initiatives.